These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 15649725)

  • 1. Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease.
    Cassar K; Bachoo P; Ford I; Greaves M; Brittenden J
    Eur J Vasc Endovasc Surg; 2005 Feb; 29(2):171-6. PubMed ID: 15649725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent pneumatic compression in stable claudicants: effect on hemostasis and endothelial function.
    Sutkowska E; Wozniewski M; Gamian A; Gosk-Bierska I; Alexewicz P; Sutkowski K; Wysokinski WE
    Int Angiol; 2009 Oct; 28(5):373-9. PubMed ID: 19935591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial cell activation and blood coagulation in critically ill patients with lung injury.
    Wenzel C; Kofler J; Locker GJ; Laczika K; Quehenberger P; Frass M; Knöbl P
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):853-8. PubMed ID: 12503477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clopidogrel has no effect on D-dimer and thrombin-antithrombin III levels in patients with peripheral arterial disease undergoing peripheral percutaneous transluminal angioplasty.
    Cassar K; Bachoo P; Ford I; Greaves M; Brittenden J
    J Vasc Surg; 2005 Aug; 42(2):252-8. PubMed ID: 16102623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation in diabetic and non-diabetic claudicants.
    Gosk-Bierska I; Adamiec R; Alexewicz P; Wysokinski WE
    Int Angiol; 2002 Jun; 21(2):128-33. PubMed ID: 12110772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
    Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
    Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet monocyte aggregates and monocyte chemoattractant protein-1 are not inhibited by aspirin in critical limb ischaemia.
    Cleanthis M; Bhattacharya V; Smout J; Ashour H; Stansby G
    Eur J Vasc Endovasc Surg; 2007 Jun; 33(6):725-30. PubMed ID: 17296320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor.
    Makin AJ; Blann AD; Chung NA; Silverman SH; Lip GY
    Eur Heart J; 2004 Mar; 25(5):371-6. PubMed ID: 15033248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
    Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of coagulation and fibrinolytic systems in patients with CLI is not normalized after surgical revascularisation.
    Pärsson H; Holmberg A; Siegbahn A; Bergqvist D
    Eur J Vasc Endovasc Surg; 2004 Feb; 27(2):186-92. PubMed ID: 14718902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between hemostatic factors and the platelet index in patients with ischemic heart disease.
    Ihara A; Kawamoto T; Matsumoto K; Shouno S; Morimoto T; Noma Y
    Pathophysiol Haemost Thromb; 2006; 35(5):388-91. PubMed ID: 17230041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation products of the haemostatic system in coronary, cerebrovascular and peripheral arterial disease.
    van der Bom JG; Bots ML; Haverkate F; Meijer P; Hofman A; Kluft C; Grobbee DE
    Thromb Haemost; 2001 Feb; 85(2):234-9. PubMed ID: 11246539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein, prothrombotic imbalance and endothelial dysfunction in acute coronary syndromes without ST elevation.
    Apetrei E; Ciobanu-Jurcuţ R; Rugină M; Gavrilă A; Uscătescu V
    Rom J Intern Med; 2004; 42(1):95-102. PubMed ID: 15529598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical revascularisation in patients with severe limb ischaemia induces a pro-thrombotic state.
    Collins P; Ford I; Greaves M; Macaulay E; Brittenden J
    Platelets; 2006 Aug; 17(5):311-7. PubMed ID: 16928603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated markers of thrombin generation and fibrinolysis in patients with active and quiescent ulcerative colitis.
    Zezos P; Papaioannou G; Nikolaidis N; Patsiaoura K; Vassiliadis T; Mpoumponaris A; Giouleme O; Evgenidis N
    Med Sci Monit; 2009 Nov; 15(11):CR563-72. PubMed ID: 19865055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
    Matsui K; Ikeda U; Murakami Y; Yoshioka T; Shimada K
    Am Heart J; 2003 Feb; 145(2):330-3. PubMed ID: 12595852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-dimers, thrombin-antithrombin complexes, and risk factors for thromboembolism in hospitalized patient.
    Pottier P; Fouassier M; Hardouin JB; Volteau C; Planchon B
    Clin Appl Thromb Hemost; 2009 Dec; 15(6):666-75. PubMed ID: 18796458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis.
    Kirmizis D; Tsiandoulas A; Pangalou M; Koutoupa E; Rozi P; Protopappa M; Barboutis K
    Med Sci Monit; 2006 Feb; 12(2):CR55-62. PubMed ID: 16449948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are there differences of inflammatory bio-markers between diabetic and non-diabetic patients with critical limb ischemia?
    Bertz L; Barani J; Gottsäter A; Nilsson PM; Mattiasson I; Lindblad B
    Int Angiol; 2006 Dec; 25(4):370-7. PubMed ID: 17164743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.